株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

B型肝炎:世界の治験動向

Hepatitis B Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 217846
出版日 ページ情報 英文 867 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
B型肝炎:世界の治験動向 Hepatitis B Global Clinical Trials Review, H2, 2017
出版日: 2017年09月15日 ページ情報: 英文 867 Pages
概要

当レポートでは、B型肝炎に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数:アジア太平洋地域
    • 上位5ヶ国における治験件数:欧州
    • 主要国における治験件数:北米
    • 上位5ヶ国における治験件数:中東/アフリカ地域
    • 上位5ヶ国における治験件数:中南米

G7諸国における治験件数:B型肝炎治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数:G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:B型肝炎治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - B型肝炎治療薬

有望な薬剤

最新治験ニュース:B型肝炎

治験プロファイルの基本情報

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4570CTIDB

GlobalData's clinical trial report, "Hepatitis B Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis B clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Hepatitis B Therapeutics Clinical Trials 30
  • Prominent Drugs 31
  • Latest Clinical Trials News on Hepatitis B 32
  • Aug 30, 2017: VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for Sci-B-Vac Phase 3 Clinical Program 32
  • Aug 28, 2017: Spring Bank to Present Additional Data from the First Cohort of its Ongoing SB 9200 ACHIEVE Clinical Trial at the 2017 International HBV Meeting in Washington D.C. 32
  • Aug 08, 2017: ContraVir Pharmaceuticals Selected to Present Poster on TXL at the Upcoming AASLD Meeting 2017 33
  • Aug 03, 2017: ContraVir Pharmaceuticals Selected to Present Two Posters on CRV431 at the Upcoming AASLD Meeting 2017 33
  • Jul 11, 2017: VBI Vaccines Announces Phase 3 Clinical Program for Sci-B-Vac Hepatitis B Vaccine 33
  • Jun 19, 2017: VBI Vaccines Reports Positive Outcome from Phase III Pre-IND Discussions with the FDA for Hepatitis B Vaccine, Sci-B-Vac 34
  • Jun 13, 2017: ENYO Pharma Announces Successful Completion of EYP001 First in Man Phase 1 Study 34
  • Clinical Trial Profile Snapshots 36

Appendix 865

  • Abbreviations 865
  • Definitions 865
  • Research Methodology 866
  • Secondary Research 866
  • About GlobalData 867
  • Contact Us 867
  • Source 867

List of Tables

List of Tables

  • Hepatitis B Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Hepatitis B Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
  • Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
  • Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Hepatitis B Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures

List of Figures

  • Hepatitis B Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Hepatitis B Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
  • Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
  • Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Hepatitis B Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
  • GlobalData Methodology 866
Back to Top